Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 20 of 23
Euroespes
Moira Capital Desarrollo
Spain
Active
Sector
Biotech
InvestorMoira Capital Partners
Entry
2018
Hold
8yr
eversyn
IBG Risikokapitalfonds IV
Germany
Active
Sector
Biotech
Investorbmp Ventures AG
Entry
2025
Hold
1yr
Evolving Therapeutics
Angels Capital
Spain
Active
Sector
Biotech
InvestorAngels Capital
Entry
2025
Hold
1yr
Evonetix
Molten Ventures Balance Sheet
UK
Active
Sector
Biotech
InvestorMolten Ventures
Entry
2018
Hold
8yr
Exapto
Generations powered by EDHEC
France
Active
Sector
Biotech
InvestorRing Capital
Entry
2024
Hold
2yr
Exicure
Abingworth Bioventures VI
US
Active
Sector
Biotech
InvestorAbingworth
Entry
2019
Hold
7yr
Expedition Therapeutics
Novo Holdings Venture Investments
United States
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2025
Hold
1yr
ExpressionEdits
BlueYard Capital Fund III
UK
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2024
Hold
2yr
F2G Limited
Novo Holdings Growth Investments
United Kingdom
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2016
Hold
10yr
Fermentas International
Summit Partners Growth Equity Fund VII
USA
Active
Sector
Biotech
InvestorSummit Partners
Entry
–
Fermify
Simon Capital Evergreen
Austria
Active
Sector
Biotech
InvestorSimon Capital
Entry
2023
Hold
3yr
Flamingo Therapeutics
BioDiscovery 5
France
Active
Sector
Biotech
InvestorAndera Partners
Entry
2018
Hold
8yr
FutuRx
Leaps by Bayer
Israel
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
GAMAMABS
BioDiscovery 4
France
Active
Sector
Biotech
InvestorAndera Partners
Entry
2015
Hold
11yr
Gastrotech Pharma
Nordic Biotech K/S
Denmark
Active
Sector
Biotech
InvestorNordic Biotech Advisors
Entry
2003
Hold
23yr
GC Therapeutics
Mubadala Capital Other Investments
USA
Active
Sector
Biotech
InvestorMubadala Capital
Entry
–
Gedea Biotech
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2017
Hold
9yr
Genagon Theraputics AB
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2015
Hold
11yr
Geneos Therapeutics
Flerie Invest
United States
Active
Sector
Biotech
InvestorFlerie
Entry
2022
Hold
4yr
GenEP
Angelini Ventures
United States
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
GenePlanet
Lauxera Growth II
Slovenia
Active
Sector
Biotech
InvestorLauxera Capital Partners
Entry
2026
Hold
0yr
General Biotechnologies
Kompas Fund II
United Kingdom
Active
Sector
Biotech
InvestorKompas Vc
Entry
2026
Hold
0yr
GeneratR
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2022
Hold
4yr
Geno
Novo Holdings Bioindustrial Investments
United States
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
Glionova AB
HealthCap VI
Sweden
Active
Sector
Biotech
InvestorHealthCap
Entry
2014
Hold
12yr
GlycoSpot
Spring Nordic
Denmark
Active
Sector
Biotech
InvestorSpring Nordic
Entry
2014
Hold
12yr
Gran Lab Ltd
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2024
Hold
2yr
GraphTx
Daphni Blue
France
Active
Sector
Biotech
InvestorDaphni
Entry
2026
Hold
0yr
Green Molecular
CRB Bio I
Spain
Active
Sector
Biotech
InvestorCRB Health Tech
Entry
2009
Hold
17yr
Guard Therapeutics
Industrifonden Evergreen
Sweden
Active
Sector
Biotech
InvestorIndustrifonden
Entry
2022
Hold
4yr
Henlez
Eir Ventures I
Denmark
Active
Sector
Biotech
InvestorEir Ventures
Entry
2022
Hold
4yr
HiloProbe
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2018
Hold
8yr
Hornet Therapeutics
4BIO Ventures III
UK
Active
Sector
Biotech
Investor4Bio Partners
Entry
2024
Hold
2yr
Hypesound
Vento Fund II
Italy
Active
Sector
Biotech
InvestorVento
Entry
2025
Hold
1yr
iECURE
Novo Holdings Venture Investments
United States
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
4yr
Immuneed
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2016
Hold
10yr
Immunitas Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2021
Hold
5yr
Immunorx Pharma, Inc.
TVM Life Science Innovation
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
InCarda Therapeutics Inc.
HealthCap VII
United States
Active
Sector
Biotech
InvestorHealthCap
Entry
2018
Hold
8yr
Integrated Dna Technologies
Summit Partners Portfolio
USA
Active
Sector
Biotech
InvestorSummit Partners
Entry
–
Ionlace
Heartcore Capital Fund IV
Sweden
Active
Sector
Biotech
InvestorHeartcore Capital
Entry
2023
Hold
3yr
Iscaff Pharma
GU Ventures Evergreen
Sweden
Active
Sector
Biotech
InvestorGU Ventures
Entry
2017
Hold
9yr
Iteria
Inveready Biotech III
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2026
Hold
0yr
Izote Biosciences
Nucleus Capital II
United States
Active
Sector
Biotech
InvestorNucleus Capital
Entry
2024
Hold
2yr
JLand Biotech
Evonik Venture Capital
China
Active
Sector
Biotech
InvestorEvonik Venture Capital
Entry
2024
Hold
2yr
KAHR Medical
Flerie Invest
Israel
Active
Sector
Biotech
InvestorFlerie
Entry
2012
Hold
14yr
Karuna Therapeutics
General Atlantic
United States
Active
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
Kromnigon
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2021
Hold
5yr
Kynda Biotech
FoodLabs Fund II
Germany
Active
Sector
Biotech
InvestorFoodLabs
Entry
2022
Hold
4yr
Kyron.bio
HCVC Hardware Club Fund II
France
Active
Sector
Biotech
InvestorElephants & Ventures / Hardware Club
Entry
2025
Hold
1yr